RISK FACTORS AND FREQUENCY OF METABOLIC SYNDROME AMONG ADULTS

TZ  KHAN; S GHUMRO; A JALAL; M MAQSOOD; A KOUSAR; TU HAQ; A KHAN; K GHAFOOR

doi:10.54112/bcsrj.v2024i1.1044

Authors

TZ KHAN Intensive Care Unit ( ICU ), Institute of Kidney Diseases (IKD) - MTI- HMC Hayatabad Peshawar, Pakistan
S GHUMRO University Shah Abdul Latif University Khairpur Mir's Sindh, Pakistan
A JALAL Department of Biochemistry, Sahara Medical College, Pakistan
M MAQSOOD Department of Bioinformatics & Biotechnology, Faculty of Life Sciences, Government College University Faisalabad Pakistan
A KOUSAR Sahara Medical College Muridke Road, Narowal, Punjab, Pakistan
TU HAQ Abbottabad International Medical Institute Abbottabad, Pakistan
A KHAN Department of Environmental Science, University of Haripur, Pakistan
K GHAFOOR Department of Microbiology and Molecular Genetics, University of Okara, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1044

Keywords:

Metabolic syndrome,, Risk factors, , Frequency,, Adults,

Abstract

Non-communicable diseases (NCDs) pose a significant public health challenge in developing nations, accounting for the most critical mortality rates and illness burden globally. Approximately 74% of annual worldwide deaths are attributed to non-communicable diseases (NCDs), with 77% of these fatalities happening in nations with low or middle incomes. The global prevalence of metabolic syndrome is recognized as a significant public health concern due to its correlation with an increased risk of developing diabetes and cardiovascular issues in individuals of all age groups, including adults, teens, and children. Objective: To determine the risk factors and frequency of metabolic syndrome among adults. Methods: The current study was a sectional study at HMC Hayatabad Peshawar. This study lasted one year, from April 2023 to April 2024. The total sample size was 1000, determined using the WHO sample size calculator. Experts collected anthropometric measurements, including weight and height. A standardized sphygmomanometer was employed to assess blood pressure. Blood samples were obtained from each subject. The data was analyzed using the SPSS version 23 program. Results: This research had a total of 1000 participants. In our study, there were 550 (55%) male participants, and 450 individuals (35%) identified as female. The average (standard deviation) age was 43.05 (11.2) years. Metabolic syndrome was found to be present in 350 (35%) of the participants. In our research, we found that obese individuals had an odds ratio (OR) of 15.01, individuals aged 51 years or older had an OR of 5.91, and overweight participants had an OR of 5.91. These findings indicate that these groups are at a much higher risk of developing metabolic syndrome. Conclusion: Our research findings suggest that metabolic syndrome is quite frequent in our community, with a higher occurrence among females. According to our research, the primary characteristics that significantly impact participation include hyperglycemia, hypertension, abdominal obesity, high levels of triglycerides, and low levels of high-density lipoprotein (HDL).

Downloads

Download data is not yet available.

References

DeBoer MD. Assessing and managing the metabolic syndrome in children and adolescents. Nutrients. 2019;11(8):1788.

Zimmet P, Alberti K, Shaw J. International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. Diabetes voice. 2005;50:31-3.

Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Comprehensive physiology. 2013;3(1):1.

Malik S, Wong ND, Franklin SS, Kamath TV, L’Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245-50.

Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Archives of pediatrics & adolescent medicine. 2003;157(8):821-7.

Lobstein T, Baur L, Uauy R. Obesity in children and young people: a crisis in public health. Obesity reviews. 2004;5:4-85.

Friend A, Craig L, Turner S. The prevalence of metabolic syndrome in children: a systematic review of the literature. Metabolic syndrome and related disorders. 2013;11(2):71-80.

Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC medicine. 2011;9(1):1-13.

Milici N, editor A short history of the metabolic syndrome definitions. Proc Rom Acad; 2010.

Márquez-Sandoval F, Macedo-Ojeda G, Viramontes-Hörner D, Ballart JF, Salvadó JS, Vizmanos B. The prevalence of metabolic syndrome in Latin America: a systematic review. Public health nutrition. 2011;14(10):1702-13.

de Carvalho Vidigal F, Bressan J, Babio N, Salas-Salvadó J. Prevalence of metabolic syndrome in Brazilian adults: a systematic review. BMC public health. 2013;13(1):1-10.

Reaven GM. The metabolic syndrome: requiescat in pace. Clinical chemistry. 2005;51(6):931-8.

Day C. Metabolic syndrome, or What you will: definitions and epidemiology. Diabetes and vascular disease research. 2007;4(1):32-8.

Vasudevan AR, Ballantyne CM. Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitus. Clinical cornerstone. 2005;7(2-3):7-16.

Iqbal Hydrie MZ, Shera AS, Fawwad A, Basit A, Hussain D Sc A. Prevalence of metabolic syndrome in urban Pakistan (Karachi): comparison of newly proposed International Diabetes Federation and modified Adult Treatment Panel III criteria. Metabolic syndrome and related disorders. 2009;7(2):119-24.

Ahmad M, Hassan S, Hafeez F, Jajja A. Prevalence of various components of metabolic syndrome in our younger population. Pakistan Journal of Physiology. 2011;7(2):46-8.

Sharma SK, Ghimire A, Radhakrishnan J, Thapa L, Shrestha NR, Paudel N, et al. Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal. International journal of hypertension. 2011;2011.

Zahid N, Claussen B, Hussain A. High prevalence of obesity, dyslipidemia and metabolic syndrome in a rural area in Pakistan. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2008;2(1):13-9.

Ali NS, Khuwaja AK, Nanji K. Retrospective analysis of metabolic syndrome: Prevalence and distribution in executive population in urban Pakistan. International journal of family medicine. 2012;2012.

Dandji M, Zambou F, Dangang D, Nana F, Tchouanguep F. Prevalence of metabolic syndrome in adult men of the dschang health district in Western-Cameroon. World Journal of Nutrition and Health. 2018;6(1):1-10.

Lee SE, Han K, Kang YM, Kim S-O, Cho YK, Ko KS, et al. Trends in the prevalence of metabolic syndrome and its components in South Korea: Findings from the Korean National Health Insurance Service Database (2009–2013). PloS one. 2018;13(3):e0194490.

El Brini O, Akhouayri O, Gamal A, Mesfioui A, Benazzouz B. Prevalence of metabolic syndrome and its components based on a harmonious definition among adults in Morocco. Diabetes, metabolic syndrome and obesity: targets and therapy. 2014;7:341.

Sabir AA, Jimoh A, Iwuala SO, Isezuo SA, Bilbis LS, Aminu KU, et al. Metabolic syndrome in urban city of North-Western Nigeria: prevalence and determinants. Pan African Medical Journal. 2016;23(1).

Owolabi EO, Ter Goon D, Adeniyi OV, Adedokun AO, Seekoe E. Prevalence and correlates of metabolic syndrome among adults attending healthcare facilities in Eastern Cape, South Africa. The Open Public Health Journal. 2017;10(1).

Belfki H, Ali SB, Aounallah-Skhiri H, Traissac P, Bougatef S, Maire B, et al. Prevalence and determinants of the metabolic syndrome among Tunisian adults: results of the Transition and Health Impact in North Africa (TAHINA) project. Public health nutrition. 2013;16(4):582-90.

Santos AC, Severo M, Barros H. Incidence and risk factors for the metabolic syndrome in an urban South European population. Preventive Medicine. 2010;50(3):99-105.

Schneider JG, Tompkins C, Blumenthal RS, Mora S. The metabolic syndrome in women. Cardiology in review. 2006;14(6):286-91.

BeLue R, Okoror TA, Iwelunmor J, Taylor KD, Degboe AN, Agyemang C, et al. An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective. Globalization and health. 2009;5(1):1-12.

Saklayen MG. The global epidemic of the metabolic syndrome. Current hypertension reports. 2018;20(2):1-8.

Kaur J. A comprehensive review on metabolic syndrome. Cardiology research and practice. 2014;2014.

Ki N-K, Lee H-K, Cho J-H, Kim S-C, Kim N-S. Factors affecting metabolic syndrome by lifestyle. Journal of physical therapy science. 2016;28(1):38-45.

Moreira GC, Cipullo JP, Ciorlia LAS, Cesarino CB, Vilela-Martin JF. Prevalence of metabolic syndrome: association with risk factors and cardiovascular complications in an urban population. PloS one. 2014;9(9):e105056.